Cancer vaccines based on resected tumors from patients have gained great interest as an
individualized cancer treatment strategy. However, eliciting a robust therapeutic effect with …

Tumor vaccines, a type of personalized tumor immunotherapy, have developed rapidly in
recent decades. These vaccines evoke tumor antigen-specific T cells to achieve immune …

Cancer nanovaccines have the ability to train the immune system to specifically recognize
and eliminate tumor cells. However, the vaccine's efficacy is hampered by limited access to …

Most cancer vaccines are unsuccessful in eliciting clinically relevant effects. Without using
exogenous antigens and adoptive cells, we show a concept of utilizing biologically …

Autologous tumor cell vaccine is an individualized tumor treatment strategy to elicit tumor‐
specific immune responses. However, it is difficult to exert efficacy in “cold” tumors, which …

Here we present a protocol for the construction and use of two types of nanocarrier based on
bacterial membrane materials for cancer vaccine delivery. Cancer vaccines induce tumor …

Tumor vaccination is a promising approach for tumor immunotherapy because it presents
high specificity and few side effects. However, tumor vaccines that contain only a single …

Despite the promise and advantages of autologous cancer cell vaccination, it remains
challenging to induce potent anti-tumor immune responses with traditional immunization …

Neoantigens induced by random mutations and specific to an individual's cancer are the
most important tumor antigens recognized by T cells. Among immunologically “cold” tumors …

The occurrence and development of tumors depend on the tumor microenvironment (TME),
which is made of various immune cells, activated fibroblasts, basement membrane …